Traditionally, viruses have been thought of as a burden that cause disease. Now, viruses are being harnessed to tackle ...

Biotech firms are engineering smarter, safer gene delivery systems to enhance the safety and efficacy of genetic medicines.

Isolere Bio by Donaldson, an innovative bioprocessing technology provider, proudly announces the availability of its manufacturing-grade IsoTagtm AAV reagent for the purification of Adeno-associated ...

Isolere Bio by Donaldson, an innovative bioprocessing technology provider, proudly announces the availability of its ...

Beckman Coulter Life Sciences, a Danaher company and a global leader in laboratory automation and innovation, announces the ...

CHOP researchers find gene therapy shows long-term benefits for haemophilia B patients: Philadelphia, Pennsylvania Monday, April 21, 2025, 10:00 Hrs [IST] Researchers at Childrens ...

D Molecular Therapeutics, Inc.’s FDMT share price has surged by 5.88%, which has investors questioning if this is right time ...

The main problem is that most vector production technologies were developed for the lab, rather than to support industrial supply, ...

The global gene therapy market is projected to grow at a significant CAGR of 20% from 2024 to 2029. This growth is driven by ...

The Viral Vector & Plasmid DNA Manufacturing Market Size accounted for USD 5.4 Billion in 2023 and is estimated to achieve a ...

Over the last few decades, various viral and non-viral vectors have been optimized and standardized for the purpose of gene delivery. It is worth mentioning that, till date, over 30 viral vector ...